Validation of the UKPDS 82 risk equations within the Cardiff Diabetes Model

por McEwan, Philip, Ward, Thomas, Bennett, Hayley, Bergenheim, Klas
Publicado 2015

Evaluation of the cost effectiveness of exenatide versus insulin glargine in patients with sub-optimally controlled Type 2 diabetes in the United Kingdom

por Woehl, Anette, Evans, Mark, Tetlow, Anthony P, McEwan, Philip
Publicado 2008

Factors Predictive of Weight Gain and Implications for Modeling in Type 2 Diabetes Patients Initiating Metformin and Sulfonylurea Combination Therapy

por Gordon, Jason P., Evans, Marc, Puelles, Jorge, McEwan, Philip C.
Publicado 2015

Healthcare resource implications of hypoglycemia-related hospital admissions and inpatient hypoglycemia: retrospective record-linked cohort studies in England

por McEwan, Philip, Larsen Thorsted, Brian, Wolden, Michael, Jacobsen, Judith, Evans, Marc
Publicado 2015

Improved glycaemic control by switching from insulin NPH to insulin glargine: a retrospective observational study

por Sharplin, Peter, Gordon, Jason, Peters, John R, Tetlow, Anthony P, Longman, Andrea J, McEwan, Philip
Publicado 2009

Switching from premixed insulin to glargine-based insulin regimen improves glycaemic control in patients with type 1 or type 2 diabetes: a retrospective primary care-based analysis

por Sharplin, Peter, Gordon, Jason, Peters, John R, Tetlow, Anthony P, Longman, Andrea J, McEwan, Philip
Publicado 2009